The Good, the Bad and the Ugly includes optimism and pessimism from the founder of the world's biggest hedge fund.» Read More
Oscar Schafer, Rivulet Capital chairman, shares his thoughts on the M&A space and investing in a low-growth environment.
AT&T is in active talks to buy satellite-TV provider DirecTV and may complete a deal in the next few weeks, according to media reports.
CNBC's Meg Tirrell reports the latest details on U.S. drugmaker Pfizer's bid to buy AstrZeneca.
David Krantz, YP CEO, explains how company is transforming itself for the mobile age.
David Blitzer, S&P Dow Jones Indices, and Maury Harris, UBS Investment Research, share their thoughts on market valuations and whether to expect a correction in the markets.
CNBC's Julia Chatterly reports on all the market moving events from Europe, as shares move higher following record highs on the Dow and S&P 500 in the U.S.
Barbara Ryan, FTI Consulting, weighs in on Pfizer's bid to acquire AstraZeneca, and what's driving consolidation in the pharma space.
Pfizer CEO Ian speaks before British lawmakers on his company's bid for AstraZeneca, reports CNBC's Meg Tirrell.
Stocks rally as momentum stocks stabilize, bonds rise across the globe and China and India see strong gains.
Narendra Modi seems poised to win in India's general election, reports CNBC's Michelle Caruso-Cabrera. And rebels claim victory in East Ukraine's secession vote.
On Wall Street, the Russell 2000 is down while the S&P 500 is up.
Brand loyalty of Mountain Dew drinkers has fueled double-digit international growth for the beverage maker, reports CNBC's Sara Eisen.
Slow and steady wins the race. That lesson from the Aesop fable about "The Tortoise and the Hare" can also apply to the stock market, according to stock picker Oscar Schafer.
CNBC's Jim Cramer explains why he thinks Harmon would make a better buy for Apple than its acquisition of Beats.
Jeff Rosenberg, BlackRock chief investment stratesgist, shares his thoughts on the outlook for the fixed income space.
Pfizer's pursuit of AstraZeneca raises a huge public policy red flag, writes Andrew Ross Sorkin in the New York Times.
Geithner tells CNBC the foreign merger situation showed the need for the administration's 2012 corporate tax reform plan that failed to win support.
As the Washington Monument reopened, billionaire David Rubenstein—who paid for half the repairs—spoke to CNBC about the project's public-private partnership.
David Rubenstein, The Carlyle Group co-founder & co-CEO, discusses the $15 million repair of the iconic American landmark after a 5.8 magnitude earthquake damaged the monument.
David Rubenstein, The Carlyle Group co-founder & Co-CEO, shares his thoughts on his investment in streaming music service Beats.
Get the best of CNBC in your inbox